Should I buy or sell ABIVAX Société Anonyme stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ABIVAX Société Anonyme in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ABVX shares. View ABVX analyst ratings or view top-rated stocks .

What is ABIVAX Société Anonyme's stock price target for 2024?

3 brokerages have issued 1-year target prices for ABIVAX Société Anonyme's shares. Their ABVX share price targets range from $15.00 to $20.00. On average, they expect the company's stock price to reach $17.50 in the next twelve months. This suggests a possible upside of 40.0% from the stock's current price. View analysts price targets for ABVX or view top-rated stocks among Wall Street analysts .

How have ABVX shares performed in 2024?

ABIVAX Société Anonyme's stock was trading at $10.70 at the beginning of the year. Since then, ABVX stock has increased by 16.8% and is now trading at $12.50. View the best growth stocks for 2024 here .

When did ABIVAX Société Anonyme IPO?

(ABVX) raised $217 million in an initial public offering on Friday, October 20th 2023. The company issued 18,699,460 shares at a price of $11.60 per share.

When does the company's lock-up period expire?

ABIVAX Société Anonyme's lock-up period expires on Wednesday, April 17th. ABIVAX Société Anonyme had issued 18,699,460 shares in its IPO on October 20th. The total size of the offering was $216,913,736 based on an initial share price of $11.60. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the expiration of the lock-up period.

Who are ABIVAX Société Anonyme's major shareholders?

ABIVAX Société Anonyme's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Franklin Resources Inc. (1.99%).

How do I buy shares of ABIVAX Société Anonyme?

Shares of ABVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ABVX

ABIVAX Société Anonyme (ABVX) Stock Price, News & Analysis

$12.50

-0.27 (-2.11%)

(As of 02/9/2024 08:55 PM ET)

Compare

Today's Range: $12.31
▼
$12.86
50-Day Range: $10.17
▼
$13.26
52-Week Range: $7.99
▼
$14.03

Volume: 70,200 shs
Average Volume: 163,996 shs
Market Capitalization: $786.63 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $17.50

Stock Analysis Analyst Forecasts Chart Competitors Financials Ownership SEC Filings Social Media

Get ABIVAX Société Anonyme alerts:

About ABIVAX Société Anonyme Stock (NASDAQ:ABVX)

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.

ABVX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ABVX Stock News Headlines

February 9, 2024 | americanbankingnews.com

Leerink Partnrs Weighs in on ABIVAX Société Anonyme's FY2028 Earnings (NASDAQ:ABVX)

February 5, 2024 | americanbankingnews.com

Comparing ABIVAX Société Anonyme (NASDAQ:ABVX) and Ocular Therapeutix (NASDAQ:OCUL)

February 12, 2024 | The Freeport Society (Ad)

Biden Out, _______ In?

A new poll shows that two-thirds of Democrats want Biden to drop out of the 2024 race. The truth will shock you.